Journals / Türk Nöroloji Dergisi / 2009 / Cilt: 15 - Sayı: 3

Stem cell applications in amyotrophic lateral sclerosis

Amyotrofik lateral sklerozda kök hücre uygulamaları

Pages
105–108
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There is no sufficient laboratory or clinical data for designing a stem cell application trial in ALS patients for today.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Stem cell application is one of the potential treatment methods for seizing the progression of amyotrophic lateral sclerosis (ALS) and for returning motor function if ever possible.
📊
Key Findings & Data:Several different methods of stem cell application have been performed in experimental motor neuron disease models; the beneficial effects of these studies are controversial.
💡
Conclusion & Impact:There is no sufficient laboratory or clinical data for designing a stem cell application trial in ALS patients for today.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Stem cell application is one of the potential treatment methods for seizing the progression of amyotrophic lateral sclerosis (ALS) and for returning motor function if ever possible. Several different methods of stem cell application have been performed in experimental motor neuron disease models; the beneficial effects of these studies are controversial. There are few stem cell studies on ALS patients reported in the literature. The results of these studies either negative or have serious methodological problems. There is no sufficient laboratory or clinical data for designing a stem cell application trial in ALS patients for today.

Özet

Amyotrofik lateral skleroz (ALS)’un ilerleyişini durdurabilmek ve mümkünse işlev kaybını geri döndürebilmek için üzerinde çalışılan tedavi metodlarından biri de kök hücre uygulamasıdır. Deneysel motor nöron hastalığı modellerinde bugüne kadar farklı metodlarla kök hücre uygulanmış; olumlu veya olumsuz olmak üzere birbirinden farklı sonuçlar elde edilmiştir. ALS’li hastalara kök hücre uygulaması ile ilgili, uluslararası indekslere giren dergilerde yayımlanmış az sayıdaki insan çalışmalarının sonuçları ya olumsuz ya da metodolojik olarak ciddi eksiklikleri bulunan çalışmalardır. ALS hastalığında kök hücre uygulamasının tedavi edici etkisi olup olmadığının insanda araştırılabilmesi için gerekli ve yeterli laboratuvar verisi veya klinik veri bugün mevcut değildir.

🔖

Cite This Article

PARMAN, Y., ŞENER, H. Ö., ŞENGÜN, İ., KOÇ, F., OFLAZER, P. (2022). Stem cell applications in amyotrophic lateral sclerosis. Türk Nöroloji Dergisi, Cilt: 15 - Sayı: 3, 105–108. https://ajindex.com/articles/637038

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Eisen A. Amyotrophic lateral sclerosis: A 40-year personal perspective. Clin Neurosci 2009;16:505-12
  2. Henkel JS, Engelhardt JI, Siklós L, Simpson EP, Kim SH, Pan T, et al. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 2004;55:221-35
  3. Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004;27:723-49
  4. Miller RG, Bouchard JP, Duquette P, Eisen A, Gelinas D, Harati Y, et al. Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-II. Neurology 1996;47(Suppl 2):86-90
  5. Kim SU, de Vellis J. Stem cell-based cell therapy in neurological diseases: A review. J Neurosci Res Early View (Articles online advance of print) 2009 Mar 19
  6. Hedlund E, Hefferan MP, Marsala M, Isacson O. Cell therapy and stem cells in animal models of motor neuron disorders. Eur J Neurosci 2007;26:1721-37
  7. Lepore AC, Maragakis NJ. Targeted stem cell strategies in ALS. Neurochem Int 2007;50:966-75
  8. Garbuzova-Davis S, Sanberg PR. Feasibility of cell therapy for amyotrophic lateral sclerosis. Exp Neurol 2009;216:3-6
  9. Appel SH, Engelhardt JI, Henkel JS, Siklos L, Beers DR, Yen AA, et al. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology 2008;71: 1326-34
  10. Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Nasuelli N, et al. Stem cell treatment in amyotrophic lateral sclerosis. J Neurol Sci 2008;265:78-83
  11. Deda H, Inci MC, Kürekçi AE, Sav A, Kayihan K, Ozgün E, et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow derived hematopoietic stem cell transplantation: A 1-year follow-up. Cytotherapy 2009;11:18-25
  12. Martinez HR, Gonzalez-Garza MT, Moreno-Cuevas JE, Caro E, Gutierrez-Jimenez E, Segura JJ. Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy 2009;11:26-34
  13. Bek S, Kasikci T, Odabasi Z. Reinnervation cannot be interpreted as an indicator of electrophysiologic improvement in amyothrophic lateral sclerosis. Cytotherapy 2009;11:256-7
  14. Badayan I, Cudkowicz ME. Is it too soon for mesenchymal stem cell trials in people with ALS? Amyotroph Lateral Scler 2008;9:321-2
  15. Mazzini L, Vercelli A, Mareschi K, Ferrero I, Testa L, Fagioli F. Mesenchimal stem cells for ALS patients. Amyotroph Lateral Scler 2009;10:123-4
  16. Patoine B